A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
Novartis receives FDA Breakthrough Therapy designation for Scemblix in 1L CML
Published:
May 11, 2024
by Contify Life Science News
|
RI S2820: Substitutes federal code lists for state-controlled substances lists.
Published:
May 10, 2024
by Rhode Island 2024 Regular Session
|
MA S704: Prohibiting discrimination against participants in the 340B drug discount program.
Published:
May 09, 2024
by Massachusetts 193rd General Court
|
MA H945: Prescription drug cost transparency and affordability bill
Published:
May 09, 2024
by Massachusetts 193rd General Court
|
Roche to host virtual event highlighting oncology products and late-stage pipeline assets, open to investors and analysts on May 31
Published:
May 08, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Ask us about our Transformation & Innovation market view